Clinical guidelines are important tools for supporting decision-making, transforming best-practice, and improving patient outcomes. Where several guidelines are available for a particular clinical topic, we develop Guidelines comparison tables to allow easy access to recommendations. Collated and reviewed by our in-house pharmacists, this Guidelines comparison table summarises the top-line recommendations on the management of hyperglycaemia in adults with type 2 diabetes from the following sources:
- the ADA/EASD consensus report, see: Davies MJ, D’Alessio DA, Fradkin J et al. (2018). Management of hyperglycaemia in type 2 diabetes. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia, 2018; 61(12), 2461–2498. The full guideline is available at: care.diabetesjournals.org/content/41/12/2669.
- NICE Guideline 28, see: National Institute for Health and Care Excellence. Type 2 diabetes in adults: management. NICE Guideline 28. NICE, 2017. The full guideline is available at: www.nice.org.uk/guidance/ng28
- SIGN Guideline 154, see: Scottish Intercollegiate Guidelines Network. Pharmacological management of glycaemic control in people with type 2 diabetes. SIGN Guideline 154. Edinburgh: SIGN; 2017. The full guideline is available at: www.sign.ac.uk/sign-116-and-154-diabetes.html
The content in this Guidelines comparison table is deliberately concise and readers are strongly advised to refer to the original guidelines and consensus report as listed above. Readers should also refer to the summary of product characteristics when a drug therapy is described.
- PDF, Size 97.39 kb